Midcourse Review  >  Table of Contents  > Focus Area 3: Cancer  >  Disparities Table

Figure 3-2. Disparities Table for Focus Area 3: Cancer
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from the baseline to the most recent data point.



Characteristics: Income, Location, and Disability
Population-based objectives Poor Near poor Middle/high income Summary index Urban or metropolitan Rural or non-metropolitan Persons with disabilities Persons without disabilities
3-1. Overall cancer deaths (1999, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.
3-2. Lung cancer deaths (1999, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.
3-3. Female breast cancer deaths
(1999, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.
Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.
3-4. Cervical cancer deaths (1999, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.
3-5. Colorectal cancer deaths (1999, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.
3-6. Oropharyngeal cancer deaths
(1999, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.
Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.
3-7. Prostate cancer deaths
(1999, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.
Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.
3-8. Melanoma cancer deaths
(1999, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.
Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.
3-9b. Sun exposure and skin cancer: 18+ years (2000, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. 10-49 percent difference from the best group rateLess than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. 10-49 percent difference from the best group rateThe group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. Decrease in disparity 10-49 percentage points (less than 10 percent from the best group rate or not statistically significant).
3-11a. Pap test ever received: females 18+ years (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Data are for Asians or Pacific Islanders. 50-99 percent difference from the best group rate10-49 percent difference from the best group rateThe group with the best rate for specified characteristic. 50-99 percent difference from the best group rate10-49 percent difference from the best group rateThe group with the best rate for specified characteristic. Best group rate reliability criterion not met.Best group rate reliability criterion not met.
3-11b. Pap test within past 3 years: females
18+ years (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Data are for Asians or Pacific Islanders.
50-99 percent difference from the best group rate50-99 percent difference from the best group rateThe group with the best rate for specified characteristic. 50-99 percent difference from the best group rateLess than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. 10-49 percent difference from the best group rateThe group with the best rate for specified characteristic.
3-12a. Fecal occult blood test within past 2 years: 50+ years (2000, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. 10-49 percent difference from the best group rateLess than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. 10-49 percent difference from the best group rateThe group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significant
3-12b. Sigmoidoscopy ever received: 50+ years (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Baseline data only. 10-49 percent difference from the best group rate10-49 percent difference from the best group rateThe group with the best rate for specified characteristic. 10-49 percent difference from the best group rateThe group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significant
3-13. Mammogram within past 2 years: females 40+ years (1998, 2003)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.Baseline data by race and ethnicity are for 1999. 50-99 percent difference from the best group rate50-99 percent difference from the best group rateThe group with the best rate for specified characteristic. 50-99 percent difference from the best group rateThe group with the best rate for specified characteristic. Less than 10 percent difference from the best group rate or not statistically significant10-49 percent difference from the best group rateThe group with the best rate for specified characteristic.
3-15. Persons living 5+ years after cancer diagnosis (1989-95, 1995-2000) Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.Characteristic not selected for this objective.

Notes:

Data for objectives 3-9a and 3-10a through h are unavailable or not applicable.

Years in parentheses represent the baseline data year and the most recent data year (if available).

Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (for example, race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary index at the most recent data point. See Technical Appendix for more information.







<<  Previous—Disparities Table: Gender and Education   |   Table of Contents   |   Next—Objectives and Subobjectives  >>


[ Top ]